LT3356398T - Monokloninių antikūnų sukūrimo būdas - Google Patents
Monokloninių antikūnų sukūrimo būdasInfo
- Publication number
- LT3356398T LT3356398T LTEPPCT/EP2016/073524T LT16073524T LT3356398T LT 3356398 T LT3356398 T LT 3356398T LT 16073524 T LT16073524 T LT 16073524T LT 3356398 T LT3356398 T LT 3356398T
- Authority
- LT
- Lithuania
- Prior art keywords
- development
- monoclonal antibodies
- monoclonal
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562234927P | 2015-09-30 | 2015-09-30 | |
PCT/EP2016/073524 WO2017055617A2 (en) | 2015-09-30 | 2016-09-30 | A method for development of monoclonal antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
LT3356398T true LT3356398T (lt) | 2023-06-12 |
Family
ID=57133140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEPPCT/EP2016/073524T LT3356398T (lt) | 2015-09-30 | 2016-09-30 | Monokloninių antikūnų sukūrimo būdas |
Country Status (12)
Country | Link |
---|---|
US (1) | US10995134B2 (lt) |
EP (1) | EP3356398B1 (lt) |
CA (1) | CA2999158A1 (lt) |
DK (1) | DK3356398T3 (lt) |
ES (1) | ES2942657T3 (lt) |
FI (1) | FI3356398T3 (lt) |
HR (1) | HRP20230384T1 (lt) |
LT (1) | LT3356398T (lt) |
PL (1) | PL3356398T3 (lt) |
PT (1) | PT3356398T (lt) |
SI (1) | SI3356398T1 (lt) |
WO (1) | WO2017055617A2 (lt) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0312481D0 (en) * | 2003-05-30 | 2003-07-09 | Celltech R&D Ltd | Antibodies |
-
2016
- 2016-09-30 EP EP16781314.6A patent/EP3356398B1/en active Active
- 2016-09-30 SI SI201631691T patent/SI3356398T1/sl unknown
- 2016-09-30 US US15/764,990 patent/US10995134B2/en active Active
- 2016-09-30 HR HRP20230384TT patent/HRP20230384T1/hr unknown
- 2016-09-30 CA CA2999158A patent/CA2999158A1/en active Pending
- 2016-09-30 ES ES16781314T patent/ES2942657T3/es active Active
- 2016-09-30 LT LTEPPCT/EP2016/073524T patent/LT3356398T/lt unknown
- 2016-09-30 PT PT167813146T patent/PT3356398T/pt unknown
- 2016-09-30 WO PCT/EP2016/073524 patent/WO2017055617A2/en active Application Filing
- 2016-09-30 PL PL16781314.6T patent/PL3356398T3/pl unknown
- 2016-09-30 FI FIEP16781314.6T patent/FI3356398T3/fi active
- 2016-09-30 DK DK16781314.6T patent/DK3356398T3/da active
Also Published As
Publication number | Publication date |
---|---|
EP3356398A2 (en) | 2018-08-08 |
WO2017055617A3 (en) | 2017-05-11 |
CA2999158A1 (en) | 2017-04-06 |
HRP20230384T1 (hr) | 2023-06-23 |
EP3356398B1 (en) | 2023-01-25 |
US20180273611A1 (en) | 2018-09-27 |
FI3356398T3 (fi) | 2023-05-03 |
SI3356398T1 (sl) | 2023-09-29 |
PL3356398T3 (pl) | 2023-10-02 |
WO2017055617A2 (en) | 2017-04-06 |
DK3356398T3 (da) | 2023-05-01 |
PT3356398T (pt) | 2023-04-28 |
US10995134B2 (en) | 2021-05-04 |
ES2942657T3 (es) | 2023-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288649A (en) | Human antibodies against tau | |
HK1258057A1 (zh) | Ii型抗cd20抗體用於降低抗藥物抗體形成 | |
ZA201803874B (en) | Humanized anti-cd73 antibodies | |
HK1257164A1 (zh) | 新型抗pd-l1抗體 | |
HK1246324A1 (zh) | 抗pd-l1抗體 | |
IL255727A (en) | Novel anti-pd-l1 antibodies | |
SG11201709908QA (en) | Method for quantifying monoclonal antibody | |
EP3283512A4 (en) | Method for mass humanization of non-human antibodies | |
SG11201705252UA (en) | Anti-pd-1 monoclonal antibodies and obtaining method thereof | |
HK1258375A1 (zh) | 人源化抗-cll-1抗體 | |
SG11201707318PA (en) | Method for detecting monoclonal antibody using mass spectrometry | |
IL256579A (en) | Human antibodies | |
IL247285A0 (en) | Monoclonal antibodies against the Marburg virus | |
IL262776A (en) | Human anti-il-1r3 antibodies | |
EP3092002A4 (en) | Method of purifying monoclonal antibodies | |
PL3371216T3 (pl) | Humanizowane przeciwciała anty-BAG3 | |
GB201704115D0 (en) | Method of selecting for antibodies | |
EP3336172A4 (en) | Method for producing antigen specific monoclonal antibody | |
GB201511508D0 (en) | Method for determining a size of biomolecules | |
LT3356398T (lt) | Monokloninių antikūnų sukūrimo būdas | |
GB201511196D0 (en) | Monoclonal antibodies | |
GB201515070D0 (en) | Method for determining affinity of a biomolecule | |
EP3371592C0 (en) | METHOD FOR QUANTIFYING THERAPEUTIC ANTIBODIES | |
PT3521307T (pt) | Método para aquisição de anticorpos |